6-156778292-ACAGCAGCAGCAGCAGCAG-ACAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP3BP6_Very_StrongBS2

The NM_001374828.1(ARID1B):​c.630_635delGCAGCA​(p.Gln211_Gln212del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000929 in 1,518,244 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. Q210Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000096 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000093 ( 0 hom. )

Consequence

ARID1B
NM_001374828.1 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 2.46

Publications

12 publications found
Variant links:
Genes affected
ARID1B (HGNC:18040): (AT-rich interaction domain 1B) This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
ARID1B Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina, ClinGen
  • Coffin-Siris syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001374828.1
BP6
Variant 6-156778292-ACAGCAG-A is Benign according to our data. Variant chr6-156778292-ACAGCAG-A is described in ClinVar as Likely_benign. ClinVar VariationId is 589319.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 14 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001374828.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARID1B
NM_001374828.1
MANE Select
c.630_635delGCAGCAp.Gln211_Gln212del
disruptive_inframe_deletion
Exon 1 of 20NP_001361757.1
ARID1B
NM_001438482.1
c.630_635delGCAGCAp.Gln211_Gln212del
disruptive_inframe_deletion
Exon 1 of 21NP_001425411.1
ARID1B
NM_001438483.1
c.630_635delGCAGCAp.Gln211_Gln212del
disruptive_inframe_deletion
Exon 1 of 21NP_001425412.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARID1B
ENST00000636930.2
TSL:2 MANE Select
c.630_635delGCAGCAp.Gln211_Gln212del
disruptive_inframe_deletion
Exon 1 of 20ENSP00000490491.2
ARID1B
ENST00000346085.10
TSL:1
c.630_635delGCAGCAp.Gln211_Gln212del
disruptive_inframe_deletion
Exon 2 of 21ENSP00000344546.5
ARID1B
ENST00000350026.11
TSL:1
c.630_635delGCAGCAp.Gln211_Gln212del
disruptive_inframe_deletion
Exon 1 of 19ENSP00000055163.8

Frequencies

GnomAD3 genomes
AF:
0.0000964
AC:
14
AN:
145298
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000110
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000668
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000119
Gnomad OTH
AF:
0.000501
GnomAD4 exome
AF:
0.0000925
AC:
127
AN:
1372946
Hom.:
0
AF XY:
0.000115
AC XY:
78
AN XY:
677766
show subpopulations
African (AFR)
AF:
0.0000357
AC:
1
AN:
28048
American (AMR)
AF:
0.000171
AC:
6
AN:
35068
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24812
East Asian (EAS)
AF:
0.000115
AC:
4
AN:
34778
South Asian (SAS)
AF:
0.000153
AC:
12
AN:
78520
European-Finnish (FIN)
AF:
0.0000235
AC:
1
AN:
42474
Middle Eastern (MID)
AF:
0.000181
AC:
1
AN:
5526
European-Non Finnish (NFE)
AF:
0.0000900
AC:
96
AN:
1066898
Other (OTH)
AF:
0.000106
AC:
6
AN:
56822
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.411
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000964
AC:
14
AN:
145298
Hom.:
0
Cov.:
31
AF XY:
0.000127
AC XY:
9
AN XY:
71036
show subpopulations
African (AFR)
AF:
0.000110
AC:
4
AN:
36340
American (AMR)
AF:
0.0000668
AC:
1
AN:
14968
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3414
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4958
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4774
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10448
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
306
European-Non Finnish (NFE)
AF:
0.000119
AC:
8
AN:
67182
Other (OTH)
AF:
0.000501
AC:
1
AN:
1998
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 22, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ARID1B: BP3

Inborn genetic diseases Benign:1
May 17, 2018
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

See cases Benign:1
Feb 25, 2020
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACMG classification criteria: PM2, BP3, BP4

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.5
Mutation Taster
=173/27
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587779744; hg19: chr6-157099426; API